CRISPR THERAPEUTICS
LIVE

Serial Number

90715256

Owner

CRISPR Therapeutics AG

Attorney

Tiffany D. Gehrke

First Use Date

Nov 1, 2013

Filing Date

May 17, 2021

Add to watchlist:

No watchlists yet
View on USPTO

CRISPR THERAPEUTICS Trademark

Serial Number: 90715256 • Registration: 6724517

CRISPR THERAPEUTICS is a trademark filed by CRISPR Therapeutics AG on May 17, 2021. The trademark is classified under Class 41 (Education & Entertainment), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

CRISPR Therapeutics AG (50 trademarks)

ZUG V8 6300 , CH

Entity Type: 99

Trademark Details

Filing Date

May 17, 2021

Registration Date

May 24, 2022

First Use Anywhere

November 1, 2013

First Use in Commerce

November 1, 2013

Published for Opposition

February 22, 2022

Goods & Services

Education services, namely, providing on-line non-downloadable articles and newsletters in the field of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy

Scientific research and development, namely, gene editing for researching and developing human cells and pharmaceuticals; research and development of therapeutics pharmaceuticals using gene editing; pharmaceutical, medical, scientific, and biopharmaceutical research and development; medical laboratory services; scientific laboratory services; custom cell-line engineering services; medical and scientific research in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; providing medical research and scientific research information in the fields of pharmaceuticals, genetics, genome editing, gene editing, genome engineering, gene modulation, transcriptional regulation, transcriptional modulation, genetic diseases, gene therapy and cell therapy; scientific research and development services relating to targeting genetic therapies to individuals

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 24, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 24, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 22, 2022 NPUB
PUBLISHED FOR OPPOSITION
Feb 22, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 2, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 19, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 19, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 19, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 19, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 19, 2022 CNEA
ASSIGNED TO EXAMINER
Jan 11, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 14, 2021 NWOS
NEW APPLICATION ENTERED
May 20, 2021 NWAP